Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 4:30 AM UTC
| NCT Number | NCT04024761 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 50 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | June 17, 2026 (Jun 17, 2026) |
As of September 1, 2026: Clinical trial NCT04024761 is currently recruiting participants. This phase1 study for acute myeloid leukemia is actively seeking new participants at 2 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04024761 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04024761 was last updated Jun 17, 2026 (June 17, 2026). HelloStudys verifies this status automatically.